Global Botanical and Plant Derived Drugs Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 13-Jul-2021
No. of pages: 100
Inquire Before Buying

Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.

Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.

Market Analysis and Insights: Global Botanical and Plant Derived Drugs Market

The global Botanical and Plant Derived Drugs market size is projected to reach US$ 37100 million by 2027, from US$ 28140 million in 2020, at a CAGR of 3.6% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botanical and Plant Derived Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botanical and Plant Derived Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botanical and Plant Derived Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botanical and Plant Derived Drugs market.

Global Botanical and Plant Derived Drugs Scope and Market Size

Botanical and Plant Derived Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Botanical and Plant Derived Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Tablets

- Capsules

- Pills

- Injections

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Drug Stores

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abott Laboratories

- Bayer Healthcare

- Bionova

- Bristol Myers

- Curapharm

Global Botanical and Plant Derived Drugs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Pills
1.2.5 Injections
1.3 Market by Application
1.3.1 Global Botanical and Plant Derived Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Botanical and Plant Derived Drugs Market Perspective (2016-2027)
2.2 Botanical and Plant Derived Drugs Growth Trends by Regions
2.2.1 Botanical and Plant Derived Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Botanical and Plant Derived Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Botanical and Plant Derived Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Botanical and Plant Derived Drugs Industry Dynamic
2.3.1 Botanical and Plant Derived Drugs Market Trends
2.3.2 Botanical and Plant Derived Drugs Market Drivers
2.3.3 Botanical and Plant Derived Drugs Market Challenges
2.3.4 Botanical and Plant Derived Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical and Plant Derived Drugs Players by Revenue
3.1.1 Global Top Botanical and Plant Derived Drugs Players by Revenue (2016-2021)
3.1.2 Global Botanical and Plant Derived Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Botanical and Plant Derived Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Botanical and Plant Derived Drugs Revenue
3.4 Global Botanical and Plant Derived Drugs Market Concentration Ratio
3.4.1 Global Botanical and Plant Derived Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical and Plant Derived Drugs Revenue in 2020
3.5 Botanical and Plant Derived Drugs Key Players Head office and Area Served
3.6 Key Players Botanical and Plant Derived Drugs Product Solution and Service
3.7 Date of Enter into Botanical and Plant Derived Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical and Plant Derived Drugs Breakdown Data by Type
4.1 Global Botanical and Plant Derived Drugs Historic Market Size by Type (2016-2021)
4.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Type (2022-2027)
5 Botanical and Plant Derived Drugs Breakdown Data by Application
5.1 Global Botanical and Plant Derived Drugs Historic Market Size by Application (2016-2021)
5.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Botanical and Plant Derived Drugs Market Size (2016-2027)
6.2 North America Botanical and Plant Derived Drugs Market Size by Type
6.2.1 North America Botanical and Plant Derived Drugs Market Size by Type (2016-2021)
6.2.2 North America Botanical and Plant Derived Drugs Market Size by Type (2022-2027)
6.2.3 North America Botanical and Plant Derived Drugs Market Size by Type (2016-2027)
6.3 North America Botanical and Plant Derived Drugs Market Size by Application
6.3.1 North America Botanical and Plant Derived Drugs Market Size by Application (2016-2021)
6.3.2 North America Botanical and Plant Derived Drugs Market Size by Application (2022-2027)
6.3.3 North America Botanical and Plant Derived Drugs Market Size by Application (2016-2027)
6.4 North America Botanical and Plant Derived Drugs Market Size by Country
6.4.1 North America Botanical and Plant Derived Drugs Market Size by Country (2016-2021)
6.4.2 North America Botanical and Plant Derived Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Botanical and Plant Derived Drugs Market Size (2016-2027)
7.2 Europe Botanical and Plant Derived Drugs Market Size by Type
7.2.1 Europe Botanical and Plant Derived Drugs Market Size by Type (2016-2021)
7.2.2 Europe Botanical and Plant Derived Drugs Market Size by Type (2022-2027)
7.2.3 Europe Botanical and Plant Derived Drugs Market Size by Type (2016-2027)
7.3 Europe Botanical and Plant Derived Drugs Market Size by Application
7.3.1 Europe Botanical and Plant Derived Drugs Market Size by Application (2016-2021)
7.3.2 Europe Botanical and Plant Derived Drugs Market Size by Application (2022-2027)
7.3.3 Europe Botanical and Plant Derived Drugs Market Size by Application (2016-2027)
7.4 Europe Botanical and Plant Derived Drugs Market Size by Country
7.4.1 Europe Botanical and Plant Derived Drugs Market Size by Country (2016-2021)
7.4.2 Europe Botanical and Plant Derived Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Botanical and Plant Derived Drugs Market Size (2016-2027)
8.2 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type
8.2.1 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application
8.3.1 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region
8.4.1 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Botanical and Plant Derived Drugs Market Size (2016-2027)
9.2 Latin America Botanical and Plant Derived Drugs Market Size by Type
9.2.1 Latin America Botanical and Plant Derived Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Botanical and Plant Derived Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Botanical and Plant Derived Drugs Market Size by Type (2016-2027)
9.3 Latin America Botanical and Plant Derived Drugs Market Size by Application
9.3.1 Latin America Botanical and Plant Derived Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Botanical and Plant Derived Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Botanical and Plant Derived Drugs Market Size by Application (2016-2027)
9.4 Latin America Botanical and Plant Derived Drugs Market Size by Country
9.4.1 Latin America Botanical and Plant Derived Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Botanical and Plant Derived Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical and Plant Derived Drugs Market Size (2016-2027)
10.2 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type
10.2.1 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application
10.3.1 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country
10.4.1 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abott Laboratories
11.1.1 Abott Laboratories Company Details
11.1.2 Abott Laboratories Business Overview
11.1.3 Abott Laboratories Botanical and Plant Derived Drugs Introduction
11.1.4 Abott Laboratories Revenue in Botanical and Plant Derived Drugs Business (2016-2021)
11.1.5 Abott Laboratories Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Introduction
11.2.4 Bayer Healthcare Revenue in Botanical and Plant Derived Drugs Business (2016-2021)
11.2.5 Bayer Healthcare Recent Development
11.3 Bionova
11.3.1 Bionova Company Details
11.3.2 Bionova Business Overview
11.3.3 Bionova Botanical and Plant Derived Drugs Introduction
11.3.4 Bionova Revenue in Botanical and Plant Derived Drugs Business (2016-2021)
11.3.5 Bionova Recent Development
11.4 Bristol Myers
11.4.1 Bristol Myers Company Details
11.4.2 Bristol Myers Business Overview
11.4.3 Bristol Myers Botanical and Plant Derived Drugs Introduction
11.4.4 Bristol Myers Revenue in Botanical and Plant Derived Drugs Business (2016-2021)
11.4.5 Bristol Myers Recent Development
11.5 Curapharm
11.5.1 Curapharm Company Details
11.5.2 Curapharm Business Overview
11.5.3 Curapharm Botanical and Plant Derived Drugs Introduction
11.5.4 Curapharm Revenue in Botanical and Plant Derived Drugs Business (2016-2021)
11.5.5 Curapharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Capsules
Table 4. Key Players of Pills
Table 5. Key Players of Injections
Table 6. Global Botanical and Plant Derived Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Botanical and Plant Derived Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Botanical and Plant Derived Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Botanical and Plant Derived Drugs Market Share by Regions (2016-2021)
Table 10. Global Botanical and Plant Derived Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Botanical and Plant Derived Drugs Market Share by Regions (2022-2027)
Table 12. Botanical and Plant Derived Drugs Market Trends
Table 13. Botanical and Plant Derived Drugs Market Drivers
Table 14. Botanical and Plant Derived Drugs Market Challenges
Table 15. Botanical and Plant Derived Drugs Market Restraints
Table 16. Global Botanical and Plant Derived Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Botanical and Plant Derived Drugs Market Share by Players (2016-2021)
Table 18. Global Top Botanical and Plant Derived Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botanical and Plant Derived Drugs as of 2020)
Table 19. Ranking of Global Top Botanical and Plant Derived Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Botanical and Plant Derived Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Botanical and Plant Derived Drugs Product Solution and Service
Table 23. Date of Enter into Botanical and Plant Derived Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Botanical and Plant Derived Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Botanical and Plant Derived Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Botanical and Plant Derived Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Botanical and Plant Derived Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Botanical and Plant Derived Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Botanical and Plant Derived Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Botanical and Plant Derived Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Botanical and Plant Derived Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Botanical and Plant Derived Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Botanical and Plant Derived Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Botanical and Plant Derived Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Botanical and Plant Derived Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Botanical and Plant Derived Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Botanical and Plant Derived Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Botanical and Plant Derived Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Botanical and Plant Derived Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Botanical and Plant Derived Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Botanical and Plant Derived Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Botanical and Plant Derived Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Botanical and Plant Derived Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abott Laboratories Company Details
Table 64. Abott Laboratories Business Overview
Table 65. Abott Laboratories Botanical and Plant Derived Drugs Product
Table 66. Abott Laboratories Revenue in Botanical and Plant Derived Drugs Business (2016-2021) & (US$ Million)
Table 67. Abott Laboratories Recent Development
Table 68. Bayer Healthcare Company Details
Table 69. Bayer Healthcare Business Overview
Table 70. Bayer Healthcare Botanical and Plant Derived Drugs Product
Table 71. Bayer Healthcare Revenue in Botanical and Plant Derived Drugs Business (2016-2021) & (US$ Million)
Table 72. Bayer Healthcare Recent Development
Table 73. Bionova Company Details
Table 74. Bionova Business Overview
Table 75. Bionova Botanical and Plant Derived Drugs Product
Table 76. Bionova Revenue in Botanical and Plant Derived Drugs Business (2016-2021) & (US$ Million)
Table 77. Bionova Recent Development
Table 78. Bristol Myers Company Details
Table 79. Bristol Myers Business Overview
Table 80. Bristol Myers Botanical and Plant Derived Drugs Product
Table 81. Bristol Myers Revenue in Botanical and Plant Derived Drugs Business (2016-2021) & (US$ Million)
Table 82. Bristol Myers Recent Development
Table 83. Curapharm Company Details
Table 84. Curapharm Business Overview
Table 85. Curapharm Botanical and Plant Derived Drugs Product
Table 86. Curapharm Revenue in Botanical and Plant Derived Drugs Business (2016-2021) & (US$ Million)
Table 87. Curapharm Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical and Plant Derived Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Capsules Features
Figure 4. Pills Features
Figure 5. Injections Features
Figure 6. Global Botanical and Plant Derived Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Botanical and Plant Derived Drugs Report Years Considered
Figure 12. Global Botanical and Plant Derived Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Botanical and Plant Derived Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Botanical and Plant Derived Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Botanical and Plant Derived Drugs Market Share by Regions (2022-2027)
Figure 16. Global Botanical and Plant Derived Drugs Market Share by Players in 2020
Figure 17. Global Top Botanical and Plant Derived Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botanical and Plant Derived Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Botanical and Plant Derived Drugs Revenue in 2020
Figure 19. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Botanical and Plant Derived Drugs Market Share by Type (2016-2027)
Figure 23. North America Botanical and Plant Derived Drugs Market Share by Application (2016-2027)
Figure 24. North America Botanical and Plant Derived Drugs Market Share by Country (2016-2027)
Figure 25. United States Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Botanical and Plant Derived Drugs Market Share by Type (2016-2027)
Figure 29. Europe Botanical and Plant Derived Drugs Market Share by Application (2016-2027)
Figure 30. Europe Botanical and Plant Derived Drugs Market Share by Country (2016-2027)
Figure 31. Germany Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Botanical and Plant Derived Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Botanical and Plant Derived Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Botanical and Plant Derived Drugs Market Share by Region (2016-2027)
Figure 41. China Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Botanical and Plant Derived Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Botanical and Plant Derived Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Botanical and Plant Derived Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Botanical and Plant Derived Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Botanical and Plant Derived Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Botanical and Plant Derived Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Botanical and Plant Derived Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abott Laboratories Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2016-2021)
Figure 61. Bayer Healthcare Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2016-2021)
Figure 62. Bionova Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2016-2021)
Figure 63. Bristol Myers Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2016-2021)
Figure 64. Curapharm Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs